AKT1 E17K mutant phosphorylates caspase-9

Stable Identifier
R-HSA-2399985
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

AKT1 E17K gain-of-function mutant is expected to phosphorylate caspase-9 (CASP9), like the wild-type AKT (Cardone et al. 1998), but this has not been experimentally tested.

Literature References
PubMed ID Title Journal Year
9812896 Regulation of cell death protease caspase-9 by phosphorylation

Cardone, MH, Roy, N, Stennicke, HR, Salvesen, GS, Franke, TF, Stanbridge, E, Frisch, S, Reed, JC

Science 1998
Participants
Participant Of
Catalyst Activity
Catalyst Activity
Title
protein serine/threonine kinase activity of p-T308,S473-AKT1 E17K [cytosol]
Physical Entity
Activity
Normal reaction
Disease
Name Identifier Synonyms
cancer 162 malignant tumor, malignant neoplasm, primary cancer
Authored
Reviewed
Created